Drreddys Laboratories reported INR77.34B in Debt for its fiscal quarter ending in March of 2026.





Debt Change Date
ANI Pharmaceuticals USD 613.76M 3.28M Mar/2026
Aurora Cannabis CAD 23.86M 76.48M Mar/2026
Bayer EUR 36.45B 2.93B Dec/2025
Canopy Growth CAD 278.71M 19.38M Mar/2026
Cipla INR 6.14B 1.76B Mar/2026
Corcept Therapeutics USD 9.64M 3.53M Mar/2026
Drreddys Laboratories INR 77.34B 9.61B Mar/2026
GlaxoSmithKline GBP 19.06B 1.34B Mar/2026
Hikma Pharmaceutical USD 1.6B 46M Dec/2025
Lonza CHF 4.71B 915M Dec/2024
Novartis USD 49.01B 2.02B Jun/2026
Pacira USD 363.12M 4.53M Jun/2026
Phibro Animal Health USD 474.17M 730K Sep/2024
Prestige Brands USD 1.05B 33.86M Mar/2026
Richter Gedeon HUF 21.74B 1.93B Dec/2024
Sun Pharmaceuticals INR 46.27B 22.65B Mar/2026
Supernus Pharmaceuticals USD 40.17M 733K Jun/2026
Teva Pharmaceutical Industries USD 16.91B 187M Mar/2026